F. Lerebours

A refined molecular taxonomy of breast cancer

Mickaël Guedj, Laëtitia Marisa, Aurélien de Reyniès et al. · Oncogene · 2011 · 272 citations · Full text

Medicine, Cancer Biology, Molecular Biology +17

Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis

Arlindo R. Ferreira, Antonio Di Meglio, Barbara Pistilli et al. · Annals of Oncology · 2019 · 223 citations · Full text

Medicine, Endocrinology, Oncology +15

Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer

Paul Cottu, Véronique D’Hondt, Sylvain Dureau et al. · Annals of Oncology · 2018 · 170 citations · Full text

Medicine, Oncology, Pharmacology +15

Effect of mutated TP53 on response of advanced breast cancers to high-dose chemotherapy

P Bertheau, François Plassa, Marc Espié et al. · The Lancet · 2002 · 162 citations

Medicine, Cancer Biology, Oncology +13

Stromal lymphocyte infiltration after neoadjuvant chemotherapy is associated with aggressive residual disease and lower disease-free survival in HER2-positive breast cancer

Anne‐Sophie Hamy, Jean‐Yves Pierga, Anne Sabaila et al. · Annals of Oncology · 2017 · 90 citations · Full text

Medicine, Cancer Biology, Oncology +17